Novartis-GSK-Eli Lilly deal may affect Indian market

Swiss drug major Novartis’ multi-billion-dollar overhaul through deals with two multinational firms -- GlaxoSmithKline and Eli Lilly -- is likely to have an impact on the Indian market, too,......

India partly revokes Roche cancer drug patent

India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.Swiss newspaper Schweiz am Sonntag reported that......

Big blow: India revokes GSK cancer drug patent

India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that......

Pharma tops in patent suits

Pharmaceutical patents are just over a fourth of all patents granted in the country, but domestic drug makers account for almost all post-grant patent opposition filed, official data reveals. Of......